Klaus Peter Stengele

Title: Klaus Peter Stengele: Innovator in Oligonucleotide Conjugates

Introduction

Klaus Peter Stengele is a notable inventor based in Pleiskirchen, Germany. He has made significant contributions to the field of biotechnology, particularly in the area of oligonucleotide conjugates. His innovative work has led to the development of a patented method that enhances the manufacturing process of these important compounds.

Latest Patents

Stengele holds a patent for a "Method of manufacturing labelled oligonucleotide conjugates." This invention relates to a method for the manufacture of labeled oligonucleotide conjugates, which involves the reaction of an oligonucleotide with a labile protecting group bound to a terminal hydroxy group and a labeling compound. The process allows for the partial or complete substitution of the labile protecting group by the labeling compound through a nucleophilic substitution reaction. This advancement is crucial for various applications in molecular biology and diagnostics.

Career Highlights

Klaus Peter Stengele is currently associated with Nimblegen Systems GmbH, a company known for its innovative solutions in genomics and molecular biology. His work at Nimblegen has allowed him to collaborate with other experts in the field, further enhancing the impact of his inventions.

Collaborations

One of his notable coworkers is Evgueni Kvassiouk. Their collaboration has contributed to the advancement of technologies related to oligonucleotide conjugates, fostering innovation within their organization.

Conclusion

Klaus Peter Stengele's contributions to the field of biotechnology, particularly through his patented method for manufacturing labeled oligonucleotide conjugates, highlight his role as an influential inventor. His work continues to impact the scientific community and advance the capabilities of molecular biology.